Physician profile
Caleb Knight
NPI 1073039970
$2,241.90
in general payments reported to CMS, 2019-2025
34 companies · $471 in 2025
The $471 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $274 · 2022: $433 · 2023: $552 · 2024: $512 · 2025: $471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,535.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,535.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $319.28 | 2021-2025 | |
| Glaxosmithkline, LLC. | $252.73 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals Lp | $203.61 | 2021-2024 | Airsupra, Farxiga, Breztri |
| Dynavax Technologies Corporation | $135.55 | 2021-2025 | Heplisav-B |
| Lilly USA, LLC | $134.05 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Janssen Pharmaceuticals, INC | $115.47 | 2021-2024 | Spravato, Xarelto |
| Amgen INC. | $106.49 | 2022-2024 | Prolia, Evenity |
| Merck Sharp & Dohme LLC | $101.38 | 2022-2024 | Gardasil 9, Vaxelis, Vaxneuvance |
| Astellas Pharma US INC | $82.99 | 2023-2025 | Veozah |
| Pfizer INC. | $76.99 | 2023-2025 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $71.59 | 2022 | |
| Dexcom, INC. | $61.07 | 2023-2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $50.71 | 2023-2025 | Cologuard Collection Kit |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $46.52 | 2024-2025 | Caplyta |
| Phathom Pharmaceuticals, INC. | $45.52 | 2024-2025 | Voquezna |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $41.08 | 2024-2025 | |
| Xeris Pharmaceuticals, INC. | $38.77 | 2022-2023 | Keveyis |
| Organon LLC | $36.59 | 2021-2023 | Nexplanon |
| Biohaven Pharmaceuticals, INC. | $34.56 | 2021 | |
| Novo Nordisk INC | $30.21 | 2024-2025 | |
| Currax Pharmaceuticals LLC | $29.99 | 2022-2024 | Contrave, Onzetra Xsail |
| Lundbeck LLC | $24.89 | 2023 | Vyepti |
| Inspire Medical Systems, INC. | $23.06 | 2025 | Inspire |
| Verity Pharmaceuticals INC. | $22.56 | 2025 | Tlando |
| Alfasigma USA, INC. | $21.63 | 2021 | |
| Seqirus USA INC | $18.03 | 2022 | |
| Cranial Technologies, INC | $17.14 | 2021 | |
| Horizon Therapeutics Plc | $15.44 | 2023 | Krystexxa |
| Idorsia Pharmaceuticals US INC | $15.23 | 2023 | Quviviq |
| Lucid Diagnostics INC. | $14.73 | 2022 | |
| Axsome Therapeutics, INC. | $14.68 | 2025 | Auvelity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.53 | 2021 | |
| Genentech USA, INC. | $13.29 | 2021 | |
| Mayne Pharma Commercial LLC | $11.54 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caleb Knight listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.